2016
DOI: 10.1111/cxo.12276
|View full text |Cite
|
Sign up to set email alerts
|

Missense mutation in SLC4A11 in two Pakistani families affected with congenital hereditary endothelial dystrophy (CHED2)

Abstract: This study reports a newly identified mutation (c.2024A>C) in the SLC4A11 gene segregating with the diseased haplotype in two consanguineous Pakistani families.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
9
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(11 citation statements)
references
References 12 publications
(15 reference statements)
1
9
0
Order By: Relevance
“…Approximately 94 SLC4A11 mutations have been identified in individuals with CHED. 4,6,9,[31][32][33][34][35][36][37][38][39][40][41][42][43][44][45][46][47][48] Although a large number of these mutations result in SLC4A11 protein misfolding and failure to mature to the plasma membrane, 5,6,[49][50][51] some mutations affect SLC4A11 transporter function without impacting membrane trafficking 17,52,53 or cause aberrant SLC4A11 pre-mRNA splicing and subsequent reduced SLC4A11 expression. 47 Collectively, these observations support the hypothesis that loss of SLC4A11 function is the primary pathogenetic mechanism in CHED rather than mutant SLC4A11 protein misfolding/mislocalization in the endoplasmic reticulum (ER).…”
mentioning
confidence: 99%
“…Approximately 94 SLC4A11 mutations have been identified in individuals with CHED. 4,6,9,[31][32][33][34][35][36][37][38][39][40][41][42][43][44][45][46][47][48] Although a large number of these mutations result in SLC4A11 protein misfolding and failure to mature to the plasma membrane, 5,6,[49][50][51] some mutations affect SLC4A11 transporter function without impacting membrane trafficking 17,52,53 or cause aberrant SLC4A11 pre-mRNA splicing and subsequent reduced SLC4A11 expression. 47 Collectively, these observations support the hypothesis that loss of SLC4A11 function is the primary pathogenetic mechanism in CHED rather than mutant SLC4A11 protein misfolding/mislocalization in the endoplasmic reticulum (ER).…”
mentioning
confidence: 99%
“…SLC4A11 resides in the basolateral membrane of corneal endothelial cells, facing the corneal stroma (44). About 60 point mutants of SLC4A11 have been reported to date (1,3,12,14,18,20,22,23,34,35,38,40,46,47). Most characterized SLC4A11 mutant proteins display the intracellular retention phenotype characteristic of misfolded membrane proteins.…”
mentioning
confidence: 99%
“…Of the ϳ60 SLC4A11 point mutations that have been identified (1,2,11,16,21,24,26,27,35,37,41,42,47,48), 19 are located in the CD and the rest in the MD. Mutations are distributed, with no distinguishable pattern, throughout the protein (Fig.…”
mentioning
confidence: 99%